TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
10
|
29
|
17 |
| Financial expenses |
0
|
18
|
17 |
| Earnings before taxes |
-12
|
-10
|
-18 |
| EBITDA |
0
|
8
|
-2 |
| Total assets |
1,506
|
1,440
|
1,350 |
| Current assets |
72
|
56
|
45 |
| Current liabilities |
936
|
888
|
820 |
| Equity capital |
570
|
552
|
530 |
| - share capital |
103
|
98
|
92 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
37.8%
|
38.3%
|
39.3% |
| Turnover per employee |
10
|
29
|
17 |
| Profit as a percentage of turnover |
-120.0%
|
-34.5%
|
-105.9% |
| Return on assets (ROA) |
-0.8%
|
0.6%
|
-0.1% |
| Current ratio |
7.7%
|
6.3%
|
5.5% |
| Return on equity (ROE) |
-2.1%
|
-1.8%
|
-3.4% |
| Change turnover |
-21
|
12
|
17 |
| Change turnover % |
-67%
|
67% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.